Stay updated on BMS-813160 Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the BMS-813160 Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the BMS-813160 Combo in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include new drug information related to colorectal cancer treatments, specifically listing Gemcitabine, 5-fluorouracil (5-FU), Leucovorin, and Irinotecan, while removing extensive details about a previous study involving BMS-813160.SummaryDifference9%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to BMS-813160 Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-813160 Combo in Advanced Solid Tumors Clinical Trial page.